Earnings Miss: Tongwei Co.,Ltd Missed EPS And Analysts Are Revising Their Forecasts

It's been a good week for Tongwei Co.,Ltd (SHSE:600438) shareholders, because the company has just released its latest first-quarter results, and the shares gained 2.1% to CN¥21.70. It was a pre

Simply Wall StMay 3 08:21

What Qingdao Vland Biotech INC.'s (SHSE:603739) 26% Share Price Gain Is Not Telling You

Qingdao Vland Biotech INC. (SHSE:603739) shares have continued their recent momentum with a 26% gain in the last month alone. Unfortunately, despite the strong performance over the last month, the

Simply Wall StMay 3 06:56

Yunnan Tongwei 200,000 ton high purity crystal silicon project successfully operated at one time to become the world's first largest single-line production capacity

Gelonghui, May 2 | Tongwei reported on May 1: Currently, the world's first project with the largest single production capacity, the Yunnan Tongwei Phase II 200,000 ton high-purity crystalline silicon project, was successfully put into operation at one time. The first batch of products was successfully released. Through quality testing, all indicators reached N-type electronic grade standards, and the product purity reached 99.999999999%.

Gelonghui FinanceMay 2 14:35

A three-pronged approach! Tongwei Co., Ltd. strengthens investor confidence with its strength: full strength in increasing holdings, repurchases, and dividends

“Investor Network” Wang Jianfan In 2023, the global photovoltaic market achieved 444 GW of new installed capacity, an increase of 76% over the previous year. Among them, China took the lead, contributing 216.88GW, with a growth rate of 148%, leading the world for 11 consecutive years. Although demand continues to grow, the release of large production capacity on the supply side has led to an imbalance between supply and demand, causing prices in the industrial chain to fall and industry competition to intensify. As can be seen from the disclosure of the quarterly reports of major photovoltaic companies, the industry is currently facing significant operating pressure and market adjustments. In the face of challenges, Tongwei Co., Ltd. has shown a solid ability to withstand risks. Tongwei Co., Ltd. 2023/4

China InvestorsMay 1 13:39

Tiankang Biology (002100): Rapid cost improvement, steady financial strength

The 2023 and 1Q24 results are in line with our expectations Tiankang Biotech announced 2023 and 1Q24 results: the company achieved revenue of 190.26/3.777 billion yuan in 2023/1Q24, +12 compared to the previous year

中金公司May 1 13:26

Tiankang Biotech (002100) 2023 Annual Report and 2024 Quarterly Report Review: Multiple businesses continued their growth trend and turned losses into profits in the first quarter

Incident: The company released its 2023 annual report and 2024 quarterly report on April 29. The full year of 2023 achieved revenue of 19.03 billion yuan, +12.0% year-on-year; realized net profit of 1.36 billion yuan to mother.

民生證券May 1 00:00